![](images/graphics/blank.gif)
Clinical trial protocol for PanDox: a phase I study of targeted chemotherapy delivery to non-resectable primary pancreatic tumours using thermosensitive liposomal doxorubicin (ThermoDox®) and focused ultrasound
8
lượt xem 3
download
lượt xem 3
download
![](https://tailieu.vn/static/b2013az/templates/version1/default/images/down16x21.png)
The dense stroma of pancreatic ductal adenocarcinomas is a major barrier to drug delivery. To increase the local drug difusion gradient, high doses of chemotherapeutic agent doxorubicin can be released from thermally-sensitive liposomes (ThermoDox®) using ultrasound-mediated hyperthermia at the tumour target.
Chủ đề:
Bình luận(0) Đăng nhập để gửi bình luận!
![](images/graphics/blank.gif)
CÓ THỂ BẠN MUỐN DOWNLOAD